In 2023, the trade exchange (includes international purchases and sales) of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) was US$3.13M.
The states with the most international purchases in 2023 were Jalisco (US$1.95M), Ciudad de México (US$691k), Estado de México (US$21.1k), and Sonora (US$7.42k).
The main commercial origins of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) in 2023 were China (US$1.37M), India (US$1.26M), Germany (US$20.6k), Italy (US$8.55k), and United States (US$7.42k).
In the global context, the main exporting countries of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) in 2022 were China (US$60.9M), India (US$47.7M), and Italy (US$21.5M). In the same year, the main importing countries of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were United States (US$19.1M), India (US$16.7M), and Canada (US$16.1M).